Trevi Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Trevi Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Trevi Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Trevi Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $464k | 51k | 9.15 |
| 2025-06-30 | $244k | 45k | 5.47 |
| 2025-03-31 | $281k | 45k | 6.29 |
| 2024-12-31 | $160k | 39k | 4.12 |
| 2024-09-30 | $63k | 19k | 3.34 |
| 2024-06-30 | $56k | 19k | 2.98 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors